Cargando…

Liposomes for Tumor Targeted Therapy: A Review

Liposomes, the most widely studied nano-drug carriers in drug delivery, are sphere-shaped vesicles consisting of one or more phospholipid bilayers. Compared with traditional drug delivery systems, liposomes exhibit prominent properties that include targeted delivery, high biocompatibility, biodegrad...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shile, Chen, Yanyu, Guo, Jiancheng, Huang, Qinqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916501/
https://www.ncbi.nlm.nih.gov/pubmed/36768966
http://dx.doi.org/10.3390/ijms24032643
_version_ 1784886141409820672
author Wang, Shile
Chen, Yanyu
Guo, Jiancheng
Huang, Qinqin
author_facet Wang, Shile
Chen, Yanyu
Guo, Jiancheng
Huang, Qinqin
author_sort Wang, Shile
collection PubMed
description Liposomes, the most widely studied nano-drug carriers in drug delivery, are sphere-shaped vesicles consisting of one or more phospholipid bilayers. Compared with traditional drug delivery systems, liposomes exhibit prominent properties that include targeted delivery, high biocompatibility, biodegradability, easy functionalization, low toxicity, improvements in the sustained release of the drug it carries and improved therapeutic indices. In the wake of the rapid development of nanotechnology, the studies of liposome composition have become increasingly extensive. The molecular diversity of liposome composition, which includes long-circulating PEGylated liposomes, ligand-functionalized liposomes, stimuli-responsive liposomes, and advanced cell membrane-coated biomimetic nanocarriers, endows their drug delivery with unique physiological functions. This review describes the composition, types and preparation methods of liposomes, and discusses their targeting strategies in cancer therapy.
format Online
Article
Text
id pubmed-9916501
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99165012023-02-11 Liposomes for Tumor Targeted Therapy: A Review Wang, Shile Chen, Yanyu Guo, Jiancheng Huang, Qinqin Int J Mol Sci Review Liposomes, the most widely studied nano-drug carriers in drug delivery, are sphere-shaped vesicles consisting of one or more phospholipid bilayers. Compared with traditional drug delivery systems, liposomes exhibit prominent properties that include targeted delivery, high biocompatibility, biodegradability, easy functionalization, low toxicity, improvements in the sustained release of the drug it carries and improved therapeutic indices. In the wake of the rapid development of nanotechnology, the studies of liposome composition have become increasingly extensive. The molecular diversity of liposome composition, which includes long-circulating PEGylated liposomes, ligand-functionalized liposomes, stimuli-responsive liposomes, and advanced cell membrane-coated biomimetic nanocarriers, endows their drug delivery with unique physiological functions. This review describes the composition, types and preparation methods of liposomes, and discusses their targeting strategies in cancer therapy. MDPI 2023-01-31 /pmc/articles/PMC9916501/ /pubmed/36768966 http://dx.doi.org/10.3390/ijms24032643 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Wang, Shile
Chen, Yanyu
Guo, Jiancheng
Huang, Qinqin
Liposomes for Tumor Targeted Therapy: A Review
title Liposomes for Tumor Targeted Therapy: A Review
title_full Liposomes for Tumor Targeted Therapy: A Review
title_fullStr Liposomes for Tumor Targeted Therapy: A Review
title_full_unstemmed Liposomes for Tumor Targeted Therapy: A Review
title_short Liposomes for Tumor Targeted Therapy: A Review
title_sort liposomes for tumor targeted therapy: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916501/
https://www.ncbi.nlm.nih.gov/pubmed/36768966
http://dx.doi.org/10.3390/ijms24032643
work_keys_str_mv AT wangshile liposomesfortumortargetedtherapyareview
AT chenyanyu liposomesfortumortargetedtherapyareview
AT guojiancheng liposomesfortumortargetedtherapyareview
AT huangqinqin liposomesfortumortargetedtherapyareview